Koninklijke Research Development from 2010 to 2026
| PHG Stock | USD 28.90 0.20 0.70% |
Research Development | First Reported 2000-03-31 | Previous Quarter 402 M | Current Value 414 M | Quarterly Volatility 262.6 M |
Check Koninklijke Philips financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Koninklijke Philips' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 B, Interest Expense of 288.1 M or Total Revenue of 20.3 B, as well as many indicators such as Price To Sales Ratio of 0.79, Dividend Yield of 0.0 or PTB Ratio of 2.41. Koninklijke financial statements analysis is a perfect complement when working with Koninklijke Philips Valuation or Volatility modules.
Koninklijke | Research Development | Build AI portfolio with Koninklijke Stock |
The Research Development trend for Koninklijke Philips NV offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Koninklijke Philips is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Koninklijke Philips' Research Development Growth Pattern
Below is the plot of the Research Development of Koninklijke Philips NV over the last few years. It is Koninklijke Philips' Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Koninklijke Philips' overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Koninklijke Research Development Regression Statistics
| Arithmetic Mean | 1,839,998,469 | |
| Geometric Mean | 1,826,740,420 | |
| Coefficient Of Variation | 13.16 | |
| Mean Deviation | 164,674,139 | |
| Median | 1,790,000,000 | |
| Standard Deviation | 242,204,745 | |
| Sample Variance | 58663.1T | |
| Range | 1B | |
| R-Value | (0.33) | |
| Mean Square Error | 55784.6T | |
| R-Squared | 0.11 | |
| Significance | 0.20 | |
| Slope | (15,799,128) | |
| Total Sum of Squares | 938610.2T |
Koninklijke Research Development History
About Koninklijke Philips Financial Statements
Koninklijke Philips stakeholders use historical fundamental indicators, such as Koninklijke Philips' Research Development, to determine how well the company is positioned to perform in the future. Although Koninklijke Philips investors may analyze each financial statement separately, they are all interrelated. For example, changes in Koninklijke Philips' assets and liabilities are reflected in the revenues and expenses on Koninklijke Philips' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Koninklijke Philips NV. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 1.6 B | 1.6 B |
Currently Active Assets on Macroaxis
When determining whether Koninklijke Philips is a strong investment it is important to analyze Koninklijke Philips' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Koninklijke Philips' future performance. For an informed investment choice regarding Koninklijke Stock, refer to the following important reports:Check out the analysis of Koninklijke Philips Correlation against competitors. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Koninklijke have expansion opportunities? Factors like these will boost the valuation of Koninklijke Philips. Anticipated expansion of Koninklijke directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Koninklijke Philips demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth (0.01) | Dividend Share 0.85 | Earnings Share 0.19 | Revenue Per Share | Quarterly Revenue Growth (0.02) |
The market value of Koninklijke Philips is measured differently than its book value, which is the value of Koninklijke that is recorded on the company's balance sheet. Investors also form their own opinion of Koninklijke Philips' value that differs from its market value or its book value, called intrinsic value, which is Koninklijke Philips' true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because Koninklijke Philips' market value can be influenced by many factors that don't directly affect Koninklijke Philips' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Koninklijke Philips' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Koninklijke Philips should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Koninklijke Philips' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.